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 1 
Summary (25 words) 2 
 3 
Psychophysical and electrophysiological assessments of nociception using 4 
laser stimulation reveal a marked dysfunction of thermo-nociceptive pathways 5 
in the affected limb of patients with chronic CRPS. 6 
 7 
 8 
9 
3 
 
ABSTRACT 1 
 2 
The aim of this study was to assess the function of the thermo-nociceptive 3 
system in 25 patients with long-lasting, medium to severe refractory CRPS-1 4 
using behavioral (detection rates and reaction times) and electrophysiological 5 
(event-related brain potentials) responses to brief (50 ms) and intense 6 
(suprathreshold for Aδ-nociceptors) CO2 laser stimuli delivered to the affected 7 
and contralateral limbs, and by comparing these responses to the responses 8 
obtained in the left and right limbs of age- and sex-matched healthy controls. 9 
As compared to healthy controls and as compared to the contralateral limb, the 10 
detection rate of pricking pain related to the activation of Aδ-fibers was 11 
markedly reduced at the affected limb. Furthermore, reaction times were 12 
substantially prolonged (>100 ms in 84% of patients and >300 ms in 50% of 13 
patients). Finally, the N2 and P2 waves of laser evoked brain potentials were 14 
significantly reduced in amplitude, and their latencies were significantly 15 
increased. Taken together, our results show that in the majority of patients with 16 
chronic CRPS-1, thermo-nociceptive pathways are dysfunctional. A number of 17 
pathological mechanisms involving the peripheral nervous system and/or the 18 
central nervous system could explain our results. However, the primary or 19 
secondary nature of these observed changes remains an open question. 20 
 21 
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INTRODUCTION 1 
 2 
The symptoms of Complex Regional Pain Syndrome (CRPS) cluster into four 3 
distinct categories: (1) abnormal pain, (2) vasomotor and temperature 4 
changes, (3) sudomotor changes and edema and (4) motor dysfunction and 5 
trophic changes [13]. Two subtypes of CRPS are defined according to the 6 
absence (CRPS-1) or presence (CRPS-2) of an unequivocal nerve lesion. 7 
Although the absence of nerve lesion questions whether CRPS-1 is a true 8 
neuropathic pain condition [19, 38, 48], there is abundant evidence suggesting 9 
that neuropathological mechanisms do contribute to CRPS-1, at the level of 10 
the peripheral nervous system (PNS) [1, 36, 37, 55] and, possibly, also at the 11 
level of the central nervous system (CNS) (for a review see [20]). 12 
Drummond et al. [5] searched for anatomical and histochemical signs of 13 
sensory and sympathetic nerve alterations in skin samples of eight patients 14 
with mechanical hyperalgesia related to CRPS-1. They concluded that, as 15 
compared to skin samples obtained from the contralateral limb, there was no 16 
difference in distribution density or change in neurochemical content of 17 
sympathetic and cutaneous nociceptive fibers. In contrast, Oaklander et al. [36] 18 
reported that CRPS-1 was associated with post-traumatic focal and persistent 19 
minimal distal nerve injury (MDNI), in particular, distal degeneration of small-20 
diameter axons subserving nociception and autonomic function. In 17/18 21 
patients, axonal densities were on average reduced by 29% at the affected 22 
limb, as compared to ipsilateral and contralateral control sites. In addition, van 23 
der Laan et al. [55] examined the sural nerve from the amputated legs of eight 24 
severely affected CRPS-1 patients and found a mild to moderate loss of C-25 
fibers in 4/8 nerves. Albrecht et al. [1] also reported detectable 26 
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neuropathological findings in the surgically amputated extremities of two 1 
patients diagnosed with CRPS-1. However, in a large survey of 298 patients 2 
with upper-limb CRPS-1, Gierthmühlen et al. [11] found that about 60% of 3 
patients had “normal” small fiber afferent function, leading her to conclude that 4 
“an isolated small fiber neuropathy is unlikely to be a major mechanism in 5 
CRPS 1”. 6 
Given these conflicting reports, the objective of the present study was to 7 
assess the function of thermonociceptive pathways in 25 patients with long-8 
lasting, medium or severe CRPS-1, by comparing the psychophysical 9 
(reaction-times, rate of detection) and electrophysiological (event-related brain 10 
potentials) responses to brief infrared laser stimuli delivered to the affected vs. 11 
contralateral limb. Indeed, laser-evoked brain potentials (LEPs) are currently 12 
recognized as the most reliable diagnostic tool to assess the function of the 13 
spinothalamic system in humans [12, 52, 54]. 14 
 15 
METHODS 16 
Subjects 17 
Twenty-five patients diagnosed with CRPS-1 were recruited from the 18 
multidisciplinary Pain Clinic (Cliniques universitaires Saint-Luc, Brussels, 19 
Belgium). Diagnosis was based on the Budapest criteria [14]. Study inclusion 20 
was conditioned by the availability of medical records including detailed clinical 21 
examination and medical history in order to compute a CRPS severity score 22 
[13]. Exclusion criteria were history of a major psychiatric disorder or the 23 
inability to understand the testing procedures. 24 
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Data of healthy volunteer participants were extracted from a large database of 1 
our laboratory in order to match as close as possible the age and gender ratio 2 
of the patient group. These participants had no clinical history, symptoms or 3 
signs of peripheral or central nervous system disorder, and were not taking any 4 
medication at the time of testing or in the month before testing. As the main 5 
objective of the present investigation was to study the responses to brief and 6 
supraliminal laser stimuli directed to the affected and asymptomatic side in 7 
unilateral CRPS-1, we examined the responses from left and right limbs 8 
obtained in healthy controls with a strictly similar protocol. Informed consent 9 
was obtained from all volunteers. The study was approved by the local Ethics 10 
Committee and conducted in accordance with the principles of the Helsinki 11 
declaration. 12 
 13 
Stimulus 14 
Cutaneous heat stimuli were delivered using a CO2 laser (Université catholique 15 
de Louvain, Louvain-la-Neuve, Belgium). Stimulus duration was 50 ms and 16 
beam diameter at target was 10 mm. The energy density of the laser stimulus 17 
was adjusted individually on the asymptomatic limb or on the left hand in 18 
healthy controls to be clearly supraliminal for Aδ-nociceptor activation (9.5 2.3 19 
mJ/mm²). We did not assess thresholds on the affected side, as we expected 20 
that these thresholds would be potentially biased by emotional and cognitive 21 
factors.  22 
The stimuli elicited a clear pricking and burning sensation in the asymptomatic 23 
limb of patients and in both limbs of healthy participants. This sensation was 24 
always detected with reaction times <650 ms when stimulating the hand and 25 
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with reaction times <750 ms when stimulating the foot (i.e. reaction times 1 
compatible with the conduction velocity of myelinated Aδ-fibers). The same 2 
energy density was used at both sites within each subject. The laser beam was 3 
slightly shifted between each trial to avoid skin overheating and minimize 4 
nociceptor sensitization or habituation. 5 
 6 
Electroencephalogram (EEG) recording 7 
At least 30 stimuli were delivered at each stimulation site, in blocks of 10 trials 8 
separated by a short resting period lasting approximately one minute. The 9 
inter-stimulus interval varied between 8 and 15 s. The EEG was recorded from 10 
19 Ag-AgCl electrodes evenly placed on the scalp according to the 11 
International 10-20 system referenced to linked earlobes. In addition, the 12 
electro-oculogram was recorded from two surface electrodes, one placed 13 
below the right lower eyelid and the other placed lateral to the outer canthus of 14 
the right eye. Signals were amplified and digitized (gain: 1000; filter: 0.06 – 75 15 
Hz, sampling rate: 167 cps) using a PL-EEG recorder (Walter Graphtek, 16 
Germany). 17 
 18 
Reaction times and detection rates 19 
For each trial, participants were asked to press a button as soon as any type of 20 
sensation was perceived at the stimulation site. Reaction times (RTs) were 21 
used to distinguish between detection mediated by C-fiber input and detection 22 
mediated by Aδ-fiber input. Specifically, RTs <650 ms when stimulating the 23 
upper limbs and RTs <750 ms when stimulating the lower limbs were 24 
considered as related to the detection of Aδ-fiber input, whereas RTs ≥650 or 25 
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≥750 ms were considered as related to the detection of C-fiber input (and, 1 
hence, to the absence of detection of Aδ-fiber input). In previous studies, we 2 
have shown that, at least in healthy individuals, reaction times can be used to 3 
distinguish between detections triggered by Aδ- and C-fiber input, because of 4 
the great difference between the nerve conduction velocities of Aδ- and C-5 
fibers [3]. RTs exceeding 2500 ms, were considered as undetected. For each 6 
subject and stimulation site, two detection rates were computed. First, the 7 
absolute detection rate, corresponding to the proportion of detected trials 8 
regardless of reaction time. Second, the rate of detections with RTs <650 ms 9 
(upper limb) and <750 ms (lower limb), corresponding to the proportion of trials 10 
detected with RTs compatible with Aδ-fiber activation. 11 
Analysis of EEG data 12 
The EEG data were processed offline using BrainVision Analyzer (Brain 13 
Products GmbH, Germany) and Letswave 5 (http://letswave.webnode.com). 14 
The EEG was band-pass filtered (0.1 – 20 Hz) using a zero-lag Butterworth 15 
filter, segmented into epochs extending from -0.5 s to +2.5 s relative to 16 
stimulus onset (512 bins) and baseline-corrected (reference interval -0.5 to 0 17 
s). Epochs contaminated by eye blinks were rejected by visual inspection. 18 
Average waveforms were then computed for each participant and stimulation 19 
site. Based on their peak latency and scalp topography as originally defined by 20 
Treede et al. [51], three distinct peaks (N1, N2, P2) were characterized in the 21 
LEP waveforms obtained following stimulation of the hands, whereas two 22 
distinct peaks (N2, P2) were characterized in the LEP waveforms obtained 23 
following stimulation of the foot. The N1 latency and amplitude was measured 24 
at the temporal electrode contralateral (Tc) to the stimulated hand, referenced 25 
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to electrode Fz, following the recommendations of Valentini et al. [53]. The N2 1 
latencies and amplitudes were measured at the vertex electrode Cz referenced 2 
to linked earlobes A1A2.  3 
Single trial analysis: relating LEP amplitude and RT latency  4 
For each electrode and each time bin of the LEP waveform, the relationship 5 
between LEP amplitude and RT was assessed using linear mixed models 6 
(LMM) [26, 47] as follows: y = a*x + b*u + e. The dependent variable y 7 
represents single-trial LEP amplitudes. The independent variable x represents 8 
RTs with a*x as the fixed effect. The quantity b*u represents the random effect 9 
taking into account variability between patients and stimulation sites. The term 10 
e represents the residual error. This procedure yielded time-courses of T-11 
value, representing the strength of the relationship between LEP signal 12 
amplitude and RTs. To address the problem of multiple comparisons, the 13 
significance level (P value) was corrected using a false discovery rate (FDR) 14 
procedure [10].  15 
 16 
Statistical analysis 17 
All data are expressed as means ± standard deviation (SD). The analyses 18 
were performed separately for the lower and upper limb groups. A Two-Way 19 
Mixed ANOVA, with stimulated “limb” (affected vs. asymptomatic limb for 20 
CRPS-1 patients; left vs. right limb for healthy participants) as the within-21 
subject factor and “group” (CRPS-1 patients vs. healthy participants) as the 22 
between-subject factor was used for the analysis of psychophysical and LEP 23 
data. When appropriate, Greenhouse-Geisser correction of degrees of 24 
freedom and contrast analyses were used. The Bonferroni-Dunn test adjusted 25 
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for pairwise comparisons according to the number of paired comparisons to be 1 
performed. Significance level was set at p <0.05. The statistical analyses were 2 
performed using Aabel 3 (Gigawiz Ltd. Co. 2010) and Matlab R2006b (The 3 
MathWorks, USA). 4 
RESULTS 5 
Study population 6 
Characteristics of patients and healthy participants are reported in Table 1. 7 
Most patients were middle-aged but two female patients were adolescents with 8 
CRPS-1 in the lower limb. There was no significant difference in age and 9 
gender between the patient/control and lower/upper limb groups. As in most 10 
previous studies on CRPS (review in [33]), females were overrepresented 11 
(72%), and the lower limbs were most often involved (72%). The frequency 12 
distribution of the CRPS Severity Scores (CSS; [13]), showed two peaks; a first 13 
peak at medium scores (0.5-0.6; 36% of patients) and a second peak at high 14 
scores (0.8-1.0; 45% of patients). 15 
 16 
Psychophysical data 17 
Psychophysical data of healthy subjects and patients are summarized in Table 18 
2. In the lower-limb group, comparison of the total detection rate showed a 19 
significant interaction between the factors ‘group’ and ‘limb’ (main effect of 20 
‘group’: F= 3.675, p= 0.064; main effect of ‘limb’: F= 13.387, p= 0.0009; 21 
interaction: F= 12.655, p= 0.0011). Comparison of the detection rate with 22 
RT<750 ms (Aδ-fiber detections showed a similar interaction between the 23 
factors ‘group’ and ‘limb’ (main effect of ‘group’: F= 10.413, p= 0.003; main 24 
effect of ‘limb’: F= 38.812, p< 0.0001; interaction: F= 21.011, p< 0.0001). 25 
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Finally, comparison of RT also showed an interaction between the factors 1 
‘group’ and ‘limb’ (main effect of ‘group’: F= 8.368, p= 0.007; main effect of 2 
‘limb’: F= 29.835, p< 0.0002; interaction: F= 14.714, p= 0.0005). Post-hoc 3 
comparisons revealed that, in CRPS patients, the total detection rate was 4 
significantly decreased (-29%; T= 3.691, p< 0.001), the detection rate with 5 
RT<750 ms was even further decreased (-52%; T= 6.337, p< 0.001), and the 6 
average RT were significantly increased (+69%; T= 4.729, p< 0.001). 7 
In the upper-limb group, the total detection rate in CRPS patients differed 8 
significantly from the total detection rate in healthy controls (main effect of 9 
‘group’: F= 7.452, p= 0.018). There was no main effect of stimulated ‘limb’ (F= 10 
7.646, p= 0.171) and no interaction between the two factors (F= 8.129, p= 11 
0.334), indicating that the total detection rates were reduced in the patient 12 
group, regardless of the stimulated limb. The detection rate with RT<650 ms 13 
showed a main effect of ‘group’ (F= 14.899, p= 0.002), a main effect of the 14 
factor ‘limb’ (F= 46.667, p< 0.0001) and an interaction between the two factors 15 
(F= 46.667, p< 0.0001). Similarly, RT showed a main effect of ‘group’ (F= 16 
14.173, p= 0.003), a main effect of ‘limb’ (F= 27.537, p= 0.0002) and an 17 
interaction between the two factors (F= 29.976, p= 0.0001). Post-hoc 18 
comparisons revealed that, in CRPS-1 patients, the detection rate with RT<650 19 
ms was significantly decreased (-31%; T= 2.811, p= 0.014) and that the RT 20 
were significantly increased (+78%; T= 6.831, p< 0.001) when stimulating the 21 
affected vs. the unaffected contralateral limb. 22 
Finally, in CRPS patients, the temperature of the skin at the affected site was, 23 
on average, cooler than the temperature of the skin at the contralateral site by 24 
2.0 ±1.1 °C (range +0.2°C to -4.8°C; n = 23). 25 
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 1 
Laser evoked brain potentials 2 
Figure 1 shows the average LEP waveforms obtained from a typical CRPS-1 3 
patient. The patient is a female aged 30 years with a severe CRPS-1 (CSS: 4 
0.82) of the right foot following a Hemi-Castaing ligamentoplasty for the 5 
treatment of chronic lateral instability of the right ankle, 2.8 years before the 6 
evaluation. Laser stimuli directed to the left asymptomatic foot dorsum were 7 
always detected, and detected with a RT<750 ms in 84% of trials. The average 8 
RT was 497 ms. In contrast, laser stimuli directed to the right symptomatic foot 9 
dorsum, only 83% of laser stimuli were detected and only 1 of these stimuli 10 
was perceived with a RT<750 ms. The mean RT was 1191 ms, i.e. more than 11 
twice the latency following stimulation of the unaffected foot. Comparison of 12 
the LEP waveforms obtained following stimulation of the affected and 13 
unaffected foot shows that the latency of the N2 and P2 peaks is markedly 14 
increased following stimulation of the affected limb (∆N2= 30 ms; ∆P2= 42 ms) 15 
and that the amplitude of the N2-P2 is markedly reduced (∆N2-P2= -14 µV; -16 
50%). 17 
In the lower-limb groups, a N2-P2 complex with latencies compatible with the 18 
conduction velocity of Aδ-fibers was identified visually in all waveforms 19 
recorded in the healthy controls. In lower-limb CRPS-1 patients, the N2-P2 20 
complex was identified in all waveforms obtained from the unaffected limb and 21 
in 16/18 waveforms obtained from the affected limb (Figure 2 upper panels). 22 
Comparison of N2 latencies showed a significant interaction between the 23 
factors ‘group’ and ‘limb’ (main effect of ‘group’: F= 1.675, p= 0.0206; main 24 
effect of ‘limb’: F= 3.350, p= 0.077; interaction: F= 9.787, p= 0.004). 25 
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Comparison of P2 latencies (main effect of ‘group’: F= 0.147, p> 0.5; main 1 
effect of ‘limb’: F= 5.044, p= 0.032; interaction: F= 5.755, p= 0.023) and 2 
comparison of N2-P2 amplitudes (main effect of ‘group’: F= 0.381, p> 0.5; 3 
main effect of ‘limb’: F= 3.845, p= 0.059; interaction: F= 6.147, p= 0.019) 4 
revealed the same interaction. Post-hoc comparisons showed that, in CRPS-1 5 
patients, N2 latencies (+11%; T= 2.912, p= 0.006) and P2 latencies (+8%; T= 6 
5.755, p= 0.023) were significantly increased when stimulating the affected 7 
limb; whereas the N2-P2 amplitude was significantly decreased (-30%; T= 8 
2.941, p= 0.006). 9 
 10 
In the upper-limb groups, an N2-P2 complex was identified visually in all 11 
waveforms recorded in the healthy controls and all waveforms recorded in 12 
patients (Figure 2 lower panels). The N2-P2 complex was preceded by an 13 
earlier N1 wave, maximal over central-parietal leads of the hemisphere 14 
contralateral to the stimulated side [53]. Of note, this lateralized N1 wave was 15 
not visible when stimulating the foot dorsum. The two-way mixed model 16 
ANOVA revealed no main effect of ‘group’ (N1 latency: F= 0.336, p= >0.5; N1 17 
amplitude: F= 2.806, p= 0.120), no main effect of ‘limb’ (N1 latency: F= 1.083, 18 
p= 0.318; N1 amplitude: F= 4.168, p= 0.064) and no interaction between the 19 
two factors (N1 latency: F= 1.326, p= 0,272; N1 amplitude: F= 1.382, p= 20 
0.263). Similarly, the two-way mixed model ANOVA revealed that the latency 21 
of the N2 wave did not significantly differ across conditions (main effect of 22 
‘group’: F= 1.340, p= 0.270; main effect of ‘limb’: F= 1.720, p= 0.214; 23 
interaction: F= 0.183, p> 0.5) and that the latency of the P2 wave differed only 24 
marginally (main effect of ‘group’: F= 1.088, p= 0.047; main effect of ‘limb’: F= 25 
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4.935, p= 0.046; interaction: F= 2.907, p= 0.114). In contrast, comparison of 1 
N2-P2 amplitudes revealed a significant interaction (main effect of ‘group’: F= 2 
0.088, p> 0.5; main effect of ‘limb’: F= 3.829, p= 0.074; interaction: F= 6.443, 3 
p= 0.026). Post-hoc comparisons showed that, in CRPS patients, the latency 4 
of the P2 wave was significantly increased (+10%; T= 2.669, p= 0.018) and the 5 
N2-P2 amplitude was significantly decreased (-34%; T= 2.850, p= 0.013) 6 
following stimulation of the affected limb. 7 
 8 
Single-trial analysis of the relationship between LEP amplitude and RT latency 9 
Conventional analysis of the latencies and amplitudes of LEP peaks obtained 10 
in the average waveforms showed that in the affected limb of CRPS-1 patients, 11 
the latency of the N2 and P2 waves was significantly increased, and the 12 
amplitude of the N2-P2 complex was significantly decreased. Parallel to these 13 
changes, the RT to stimuli delivered to the affected limb was significantly 14 
increased. For this reason, we conducted a supplementary analysis aimed at 15 
specifying the relationship between the amplitude of LEP waveforms and RT at 16 
the level of single-trials [16, 18]. The analysis was performed on the 21 patient 17 
EEG recordings for which we possessed complete original data files. 18 
The results of this analysis are reported in Figure 3. A significant negative 19 
relationship between LEP amplitude and RT was observed maximally at Pz 20 
between 365 ms and 533 ms after stimulus onset, corresponding to the latency 21 
of the P2 wave. This relationship indicates that trials in which the stimulus 22 
elicited P2 waves of smaller amplitude were also trials in which the stimuli 23 
were detected with later RT.  24 
 25 
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Ultra-Late C-fiber related LEPs 1 
 2 
In two patients with lower limb CRPS-1, laser stimuli delivered to the affected 3 
limb did not elicit a clearly identifiable LEP at latencies compatible with the 4 
conduction velocities of Aδ-fibers. Interestingly, in these two patients, the 5 
stimulus elicited a later negative-positive complex at latencies compatible with 6 
the conduction of C-fibers (Figure 4).  7 
The first patient was a 57 year-old female presenting with severe CRPS-1 8 
(CSS: 0.88) at the right lower limb for 12.7 years, following a Maquet 9 
osteotomy of the right knee. Stimulation of the unaffected left foot dorsum 10 
clearly elicited LEPs compatible with the conduction velocity of Aδ-fibers (N2 11 
latency: 263 ms; P2 latency: 449 ms). However, this response was followed by 12 
a later negative-positive complex whose latency (N2’:1006 ms; P2’: 1365 ms) 13 
was compatible with the expected latency of C-fiber LEPs. Furthermore, 14 
stimulation of the affected right foot dorsum did not elicit an identifiable LEP 15 
compatible with the conduction velocity of Aδ-fibers, but did elicit a LEP 16 
compatible with the conduction velocity of C-fibers (N2’: 1156 ms; P2’: 1341 17 
ms). Such as the scalp topography of Aδ-fiber related LEPs, the C-fiber related 18 
N2’ and P2’ waves were symmetrically distributed over the two hemispheres 19 
and maximal at the scalp vertex. As shown in the lower part of Figure 4, the 20 
frequency distributions of RTs were bimodal when stimulating the unaffected 21 
limb (with a first peak of RTs around 400 ms compatible with the detection of 22 
Aδ-fiber input and a second peak of RTs around 1200 ms compatible with the 23 
detection of C-fiber input). In contrast, almost all RTs obtained when 24 
stimulating the affected limb were compatible with the conduction of C-fiber 25 
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input. However, one should be cautious when interpreting these results, as 1 
RTs are not only dependent on the time required to conduct and process the 2 
sensory input, but also on the time required for sensorimotor integration and 3 
the production of motor output. Therefore, one cannot exclude that the 4 
observed increase in RTs observed in these patients was due to an abnormal 5 
increase in the time required for sensorimotor integration and motor output. 6 
However, it seems unlikely that this could lead to an increase in the latency of 7 
the elicited responses of several hundreds of milliseconds.  8 
 9 
The second patient was a 62-year old male presenting with severe CRPS-1 10 
(CSS: 0.88) after an ankle sprain about 6.1 years before evaluation. In this 11 
patient, an Aδ-fiber LEP was identified when stimulating the unaffected limb 12 
(N2 latency: 258 ms; P2 latency: 508 ms; N2-P2 amplitude: 23.8 µV) but not 13 
when stimulating the affected limb. Instead, a C-fiber LEP was clearly visible 14 
(N2’ latency: 1060 ms; P2’ latency: 1458 ms; N2’-P2’ amplitude: 23.8 µV). The 15 
total detection rate was 82% for both limbs. However, the detection rate with 16 
RTs <750 ms was 70% when stimulating the unaffected limb, and only 2% 17 
when stimulating the affected limb. 18 
 19 
DISCUSSION  20 
In contrast to the healthy volunteers, we found that in patients with CRPS-1, 21 
(1) the total detection rate of laser stimuli and (2) the rate of detections with 22 
reaction times compatible with the conduction velocity of Aδ-fibers were both 23 
significantly reduced at the pathological limb as compared to the asymptomatic 24 
limb. Likewise, we found that reaction times were substantially prolonged in 25 
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patients versus controls (increased by more than 300 ms in 50% of patients). 1 
Analysis of the LEP waveforms showed that the latency of the N2 and P2 2 
waves obtained from the pathological limb were significantly increased. 3 
Furthermore, the amplitude of the N2-P2 complex was significantly decreased 4 
in patients versus controls. Taken together, these results indicate a dysfunction 5 
of thermo-nociceptive pathways in CRPS-1. In the following paragraphs, we 6 
discuss whether this dysfunction results from changes at the level of the PNS, 7 
the CNS, or both.  8 
 9 
Biophysical properties of the skin 10 
The chronic inflammatory state in the upper skin layers held responsible for 11 
edema and trophic changes could have altered the thermophysical properties 12 
of the skin in such a way that absorption and transmission of the CO2 laser 13 
radiation are reduced at the affected limb. Although we used stimuli that were 14 
clearly supra-threshold for AMH-2 nociceptors in the hairy skin of healthy 15 
individuals (i.e. the Aδ-fiber related LEPs), changes in biophysical properties of 16 
the affected skin cannot be ruled out entirely. 17 
An additional factor that could have contributed to the increase in RT and LEP 18 
latencies at the affected limb was the average reduction in skin temperature of 19 
2.0 ±1.1°C at the affected vs. contralateral limb. However, it seems unlikely as 20 
the latency and amplitude of the early N1 wave of LEPs elicited by stimulation 21 
of the upper limbs was not significantly different between affected and 22 
unaffected sides in CRPS-1 patients.  23 
 24 
Peripheral neuropathy 25 
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Given the well-characterized clinical signs and laboratory tests demonstrating 1 
autonomic and vasomotor dysfunction in the skin of the affected limb of CRPS-2 
1 patients, one could expect to find an associated dysfunction of peripheral 3 
nociceptive fibers (for a review see [37]). However, the multiple interactions 4 
between autonomic and nociceptive systems make it very difficult to define a 5 
causal direction and disentangle primary and secondary mechanisms. 6 
Our finding that, following stimulation of the affected limb, the latency of the N2 7 
and P2 waves was significantly increased, and the amplitude of the N2-P2 8 
complex was significantly reduced is compatible with an increased trial-to-trial 9 
jitter of response latencies [42]. However, it seems unlikely that this 10 
mechanism could have played a significant role as the latency and amplitude 11 
of the earlier N1 wave was not significantly different between groups and 12 
between sides in CRPS-1 patients. Furthermore, the standard deviations for 13 
N2-P2 amplitudes and latencies were not different between the patient and 14 
control groups and between the affected and unaffected sides in CRPS-1 15 
patients (Table 2).  16 
In many neuralgic conditions, intraepidermal nerve fiber (IENF) density is 17 
reduced [17, 27]. This might conceivably be the most prominent feature that 18 
explains all the phenomena we observed in CRPS-1. Indeed, a reduction in 19 
IENF density may explain the drop in total detection rate, the reduction in the 20 
Aδ-nociceptor related detection rate [35, 41] and the reduction in N2-P2 21 
amplitude. However, Drummond et al. [5], in a qualitative study of skin samples 22 
taken from nine patients with CRPS-1, did not find any difference in the 23 
distribution of several neuron-specific markers as compared with the skin 24 
samples taken from the contralateral side or from healthy controls. Van der 25 
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Laan et al. [55] examined nerve biopsies from eight amputated CRPS-1 limbs 1 
and found only a slight decrease of myelinated fiber density and pathology of 2 
unmyelinated fibers in four sural nerves, leading them to conclude that there 3 
was “no consistent pathology of the peripheral nerves”. In contrast, Albrecht et 4 
al. [1] found evidence of widespread cutaneous neuropathologic changes, 5 
including a marked decrease in epidermal innervation in skin samples from the 6 
amputated upper and lower extremity of two patients with CRPS-1. To our 7 
knowledge, there are only two studies reporting on IENF density in CRPS-1 8 
using skin punch biopsies stained with the pan-axonal marker PGP 9.5, a 9 
validated technic for diagnosing small fiber neuropathies [6]. The first study 10 
[36] included 18 CRPS-1 patients and reported a 30% median reduction of 11 
IENF density as compared to the contralateral limb. As pointed out by Jänig 12 
and Baron [20], in patients with diabetic and other peripheral neuropathies, a 13 
30% reduction of IENF density does not normally lead to clinically detectable 14 
changes of thermal and nociceptive sensations. The second study [23] showed 15 
that the IENF density in the affected limb of 43 CRPS-1 patients was not 16 
significantly different from the IENF density at the thigh or at the calf, or the 17 
IENF density assessed in healthy controls. Furthermore, there was no 18 
significant difference in the mean IENF density between patients with normal 19 
and abnormal sensory thresholds for warm, cold, heat-pain and cold-pain. 20 
Thus, there is no clear evidence for a structural reduction in IENF density and, 21 
hence, for a structural alteration of the PNS. 22 
To account for our results, two possibilities should be considered at the 23 
peripheral level. First, CRPS-1 could be related to changes in the function of 24 
peripheral nociceptors without any visible change in their structure. The 25 
20 
 
persistent inflammatory state of the skin could modify the normal functioning of 1 
IENF [25]. Furthermore, CRPS-induced vasoconstriction may induce hypoxia, 2 
lactate increase and acidosis, which could also contribute to nociceptor 3 
dysfunction [2, 24, 45]. Second, CRPS-1 could be related primarily to changes 4 
in the function of Aδ-nociceptors, with a relative preservation of C-fiber 5 
nociceptors. Indeed, the present study showed a marked reduction of detection 6 
rates compatible with the conduction velocity of Aδ-fibers, and a marked 7 
alteration of the LEPs related to the activation of Aδ-fibers. Furthermore, in 8 
some patients, the disappearance of the Aδ-fiber related LEP led to the 9 
appearance of a later C-fiber related LEP, suggesting that the dysfunction 10 
affected Aδ-fibers but not C-fibers (see [58] for a case reporting a similar 11 
finding). Importantly, because the number of C-fibers is thought to greatly 12 
exceed the number of Aδ-fibers [39, 46], a selective structural alteration of Aδ-13 
fiber IENFs could go largely unnoticed using currently available histological 14 
techniques to analyze skin biopsies which only assess the total IENF density, 15 
as these are unable to distinguish between C-fiber and Aδ-fiber free nerve 16 
endings. This interpretation is also compatible with the results of Gierthmühlen 17 
et al. [11] showing no impairment of thermal thresholds in approximately 60% 18 
of 298 patients with upper-limb CRPS-1. Indeed, because these thresholds 19 
were assessed using a large (900 mm2) Peltier thermode and slow heating 20 
ramps, these thresholds were likely to mainly reflect the function of C-fibers 21 
[22, 59].  22 
 23 
Central nervous system dysfunction 24 
There is accumulating evidence that the CNS plays an important role in the 25 
21 
 
maintenance and, possibly, in the initiation of the symptoms associated with 1 
CRPS-1 [33]. At the spinal level, Del Valle et al. [4] found microglial and 2 
astrocytic activation as well as significant posterior horn cell loss in autopsy 3 
tissue from the cervical, thoracic and lumbar spinal cord of a patient with 4 
longstanding CRPS-1. Using magnetoencephalography, Walton et al. [57] 5 
reported changes in the power spectrum of the recorded signals interpreted as 6 
reflecting a neurological ‘‘disconnection syndrome” resulting from a 7 
disturbance in thalamocortical interplay. An involvement of the CNS is also 8 
suggested by a number of neuropsychological symptoms associated with 9 
CRPS-1 like glove stocking sensory loss, trend to asomatognosia, referred 10 
sensations, impaired representation and discriminative abilities of the 11 
pathological limb and intentional motor dysfunction [30, 34, 43, 44].  12 
 13 
Impaired perception and utilization of the affected limb in CRPS is consistent 14 
with studies showing abnormal reorganization of the cortical activity in areas 15 
involved in sensory-motor functions [21, 31, 32, 40, 56]. Importantly, such 16 
changes could have contributed to the results of the present study, as these 17 
would predict an increased latency and decreased amplitude of the responses 18 
to nociceptive stimuli. For instance, the observed reduction in the somatotopic 19 
map of the affected limb could of course result from reduced afferent input (as 20 
observed in amputees with phantom limb pain [7]) or pain-induced reduction in 21 
responsiveness of neurons in somatosensory pathways [11]. Importantly, such 22 
a reduction in neuron responsiveness could be related to the fact that CRPS 23 
patients tend to ignore the affected limb and attentional effort is needed to 24 
move it [8]. Several studies have shown that, in healthy subjects, LEPs elicited 25 
22 
 
by stimulation of the attended limb are enhanced as compared to LEPs elicited 1 
by stimulation of the unattended limb [9, 28, 29], as observed in our CRPS 2 
patients. However, such an interpretation would not account for the 3 
dissociation between a marked alteration of the responses to Aδ-fiber input 4 
and a relative preservation of the responses to C-fiber input, possibly even 5 
leading to an “unmasking” of C-fiber LEPs in some patients.  6 
 7 
In summary, the present results show that in most patients with chronic CRPS-8 
1, the thermo-nociceptive system is markedly dysfunctional. Whether the 9 
observed dysfunction results from pathological mechanisms involving the PNS, 10 
the CNS or both remains an open question. 11 
12 
23 
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FIGURE CAPTIONS 1 
 2 
 3 
Figure 1. Average LEP waveform recorded at the vertex (Cz vs. A1-A2) after 4 
stimulation of the right and left foot dorsum of a female patient (30 years of 5 
age) presenting with CRPS-1 at the right foot for 2.8 years (severity score of 6 
0.82). Note the increased latency and reduced amplitude of the N2 and P2 7 
waves elicited by stimulation of the affected right foot (black waveform) as 8 
compared to the asymptomatic left foot (grey waveform). Scalp topographies 9 
show the distributions of the Aδ-fiber related N2 and P2 waves elicited by 10 
stimulation of the asymptomatic left foot. The vertical dashed line represents 11 
the onset of the laser stimulus. 12 
 13 
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 1 
Figure 2. Average LEP waveforms from all patients with CRPS-1 in the lower 2 
limbs (feet dorsum stimulation) and with CRPS-1 in the upper limbs (hand 3 
dorsum stimulations). The individual LEPs obtained when stimulating the 4 
asymptomatic contralateral side (left panels) and the affected CRPS side 5 
(middle panels) are shown as superimposed thin grey waveforms. The group-6 
level average is shown as a thick black line. The right panel shows the 7 
individual N2-P2 amplitudes of the LEPs obtained by stimulation of the 8 
contralateral and CRPS sides. Note that in the majority of patients, the N2-P2 9 
amplitude of LEPs is reduced at the CRPS side as compared to the 10 
contralateral side. 11 
 12 
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 1 
Figure 3. Left panel. Group-level average LEP waveform and topographic 2 
maps at Cz (blue) and Pz (red) of all patients. Right panel. The statistic T 3 
value, revealed by the linear mixed model, shows an inverse and significant 4 
relationship between LEP amplitude and reaction times, maximum at Pz 5 
between 365 ms and 533 ms (grey area in both panels). On average, trials 6 
with larger P2 amplitudes were also trials with shorter reaction times. In 7 
contrast, the amplitude of the N1 and N2 components was not significantly 8 
correlated with the RTs. This may indicate that the variability of RTs could be 9 
mainly caused by cognitive influences. 10 
 11 
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 1 
Figure 4. Average LEP waveforms recorded at the vertex (Cz vs. A1-A2) after 2 
stimulation of the right and left foot dorsum of a female patient (57 years of 3 
age) presenting with CRPS at the right limb for 12.7 years (severity score of 4 
0.88). Stimulation of the asymptomatic left foot (grey waveform) clearly elicited 5 
two distinct negative-positive waves, the first with a latency compatible with the 6 
conduction velocity of Aδ-fibers, the second with a latency compatible with the 7 
conduction velocity of C-fibers. Stimulation of the affected right foot evoked 8 
only elicited a LEP at a latency compatible with the conduction velocity of C-9 
fibers. As shown by the scalp topographies of the N2 and P2 peaks, the 10 
topographical distribution of the C-fiber related LEP was well structured with a 11 
maximum at Cz-Pz. The lower part of the figure shows the time-frequency 12 
representation of LEP amplitude averaged across trials.  13 
